Successful pregnancy in a cystic fibrosis patient with a severe impairment of lung function receiving Elexacaftor-Tezacaftor-Ivacaftor.

Cystic fibrosis Elexacaftor-Tezacaftor-Ivacaftor Impaired lung function Pregnancy

Journal

Respiratory medicine case reports
ISSN: 2213-0071
Titre abrégé: Respir Med Case Rep
Pays: England
ID NLM: 101604463

Informations de publication

Date de publication:
2022
Historique:
received: 11 09 2022
accepted: 06 11 2022
entrez: 17 11 2022
pubmed: 18 11 2022
medline: 18 11 2022
Statut: epublish

Résumé

Before the arrival of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulators women with CF and impaired lung function were experiencing a high risk of complications and mortality during and the years after pregnancy. The arrival of the highly efficient CFTR modulator, Elexacaftor-Tezacaftor-Ivacaftor (ETI) resulted in an improvement of lung function, quality of life and fertility. Here we report a case of successful pregnancy and uncomplicated delivery for a CF patient with severely impaired lung function receiving ETI prior to conception.

Identifiants

pubmed: 36386288
doi: 10.1016/j.rmcr.2022.101776
pii: S2213-0071(22)00198-8
pmc: PMC9664010
doi:

Types de publication

Case Reports

Langues

eng

Pagination

101776

Informations de copyright

© 2022 The Authors. Published by Elsevier Ltd.

Références

J Cyst Fibros. 2021 May;20(3):402-406
pubmed: 33762125
J Cyst Fibros. 2020 Jan;19(1):80-83
pubmed: 31272894
Am J Pathol. 1994 May;144(5):906-14
pubmed: 7513949
Matern Child Health J. 2017 Apr;21(4):818-824
pubmed: 27531009
Respir Med. 2018 Dec;145:200-205
pubmed: 30509709
J Clin Med. 2020 Aug 21;9(9):
pubmed: 32825766
N Engl J Med. 2019 Nov 7;381(19):1809-1819
pubmed: 31697873
Curr Opin Obstet Gynecol. 2013 Jun;25(3):167-72
pubmed: 23429570
BJOG. 2020 Dec;127(13):1696-1703
pubmed: 32683738
J Cyst Fibros. 2022 May;21(3):387-395
pubmed: 34456158
J Cyst Fibros. 2019 Jul;18(4):525-529
pubmed: 30366850

Auteurs

Zisis Balmpouzis (Z)

Adult Cystic Fibrosis and CFTR-related Disorders Center, Division of Pulmonology, Dept of Medicine, Lausanne University Hospital and University of Lausanne, Switzerland.
Lung Transplant Center, Division of Pulmonology, Dept of Medicine, Lausanne University Hospital and University of Lausanne, Switzerland.

Annabelle Faure van Rossum (A)

Operative Gynecology and Obstetrics, Private Practice, Switzerland.

David Baud (D)

Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, 1011, Lausanne, Switzerland.

Alice Panchaud (A)

Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Georgia Mitropoulou (G)

Adult Cystic Fibrosis and CFTR-related Disorders Center, Division of Pulmonology, Dept of Medicine, Lausanne University Hospital and University of Lausanne, Switzerland.
Lung Transplant Center, Division of Pulmonology, Dept of Medicine, Lausanne University Hospital and University of Lausanne, Switzerland.

Jesica Mazza Stalder (J)

Adult Cystic Fibrosis and CFTR-related Disorders Center, Division of Pulmonology, Dept of Medicine, Lausanne University Hospital and University of Lausanne, Switzerland.

Angela Koutsokera (A)

Adult Cystic Fibrosis and CFTR-related Disorders Center, Division of Pulmonology, Dept of Medicine, Lausanne University Hospital and University of Lausanne, Switzerland.
Lung Transplant Center, Division of Pulmonology, Dept of Medicine, Lausanne University Hospital and University of Lausanne, Switzerland.

Classifications MeSH